VeriSeq NIPT Solution为希望将非侵入性产前检测加入服务项的实验室提供了新一代测序方案。它可在约1天时间内为多达96个样本生成准确的结果，并提供：
VeriSeq NIPT Solution v2 uses PCR-free, whole-genome sequencing to expand prenatal screening beyond aneuploidies 21, 18, and 13 to all rare autosomal aneuploidies (RAAs), sex chromosome aneuploidies (SCAs), and partial duplications and deletions ≥7 Mb for all autosomes. This enables the VeriSeq NIPT Solution v2 to detect anomalies that targeted assays miss and deliver more insights into the health of a pregnancy.
Extensive validation of the VeriSeq NIPT Solution v2 confirmed high concordance with clinical reference data and a low test failure rate. An efficient 3-step workflow allows sample to report in 26 hours.
VeriSeq NIPT Microlab STAR是一套针对VeriSeq NIPT工作流程进行了自定义配置和优化的Hamilton Microlab STAR系统，VeriSeq NIPT Solution的样本制备可在该系统上自动进行。如需了解有关该仪器的更多信息，请访问Hamilton网站。
VeriSeq NIPT是体外诊断检测，用于通过妊娠10周及以上的孕妇的外周全血标本进行基于测序的胎儿非整倍体筛查。VeriSeq NIPT可提供有关21、18、13、X和Y染色体非整倍体状态的信息。本产品不得用作诊断或其他妊娠管理决策的唯一依据。
For In Vitro 供体外诊断使用。并非在所有国家或地区上市。
Contact an Illumina representative for regional availability.
Data Sheet | PDF | 11 versions
VeriSeq NIPT Solution v2 Package Insert Documentation
VeriSeq NIPT Solution v2 Site Prep Guide Documentation
Veriseq NIPT Solution Documentation
VeriSeq NIPT Solution v2 Consumables & Equipment List Documentation
VeriSeq NIPT Solution v2 Sample Prep Checklist Documentation
